TORONTO, Dec. 08, 2020 (GLOBE NEWSWIRE) — Skinopathy, a new Canadian medical technology start-up, is developing Artificial Intelligence technology to help fight the scourge of skin cancer.
According to the Canadian Skin Cancer Foundation, there are more new cases of skin cancer each year than the number of breast, prostate, lung, and colon cancers combined and one in every three cancers diagnosed worldwide is skin cancer.
“Unfortunately, skin cancer is often overlooked as a major threat to a person’s wellbeing,” says Dr. Colin Hong, a Toronto-based Plastic and Reconstructive surgeon and co-founder of Skinopathy. “Most forms of skin cancer probably won’t kill you, but many can lead to serious complications such as disfigurement, bleeding, and infections.”
Perhaps what is most striking is the economic burden of skin cancer. Data from the Public Health Agency of Canada suggests the costs associated with skin and subcutaneous tissue diseases was over 2 Billion Dollars in 2010.
“I had my own skin cancer scare,” says Keith Loo, co-founder of Skinopathy and Entrepreneurship Instructor at the Schulich School of Business, York University. “I met Dr. Hong a number of years ago and we got to talking about how technology might be able to help save lives.”
Skinopathy is geared to catch skin cancer, and other skin diseases, before they become serious medical concerns. The AI technology being developed will help accelerate the screening process for patients and reduce the strain on the Canadian medical system. Additionally, plans are in place to set new standards of practice in the medical field by streamlining the administrative load by automating billing, scheduling, and medical follow-ups.
This service will be integrated directly with Canadian provincial healthcare systems meaning no additional charges will be passed on to patients.
Contact
Richard Pietro
Partnerships Lead
richard@skinopathy
833-272-7546
About Skinopathy
Skinopathy is a Canadian medtech company that is modernizing how healthcare practitioners, pharmaceuticals, and cosmeceuticals are screening, tracking, and managing all skin conditions.
It was started during the pandemic when Co-Founder, Dr. Colin Hong, noticed patients were coming to his clinic presenting with late-stage skin cancer due to delayed and/or canceled skin cancer screenings.
Not only were people’s well-being at stake, but he knew that these delays would only get worse
and stretch an already taxed healthcare system to its limits.
That is when he decided to collaborate with technologist and entrepreneur, Keith Loo, MBA,
to revolutionize, digitize, and automate the entire dermatological journey. Everything from
screening to research.
About GetSkinHelp
GetSkinHelp is a teledermatology platform that leverages Skinopathy technologies on any mobile device to provide virtual consultations, skin cancer / skin disease screening, advanced triaging and differential diagnosis for a complete circle of connected virtual care.